Bertrand Lab

University of California-Irvine

INTERNAL MEDICINE/MEDICINE

Irvine · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts

Multiple myeloma (MM) is the second most common hematological malignancy and is largely incurable. Black Americans experience an unexplained 2-fold excess risk compared to White Americans, while Asian Americans experience a lower risk. MM is preceded by a precursor state characterized by an accumulation of benign monoclonal plasma cells that secrete a monoclonal protein (monoclonal gammopathy of undetermined significance, MGUS), which occurs with the same racial/ethnic disparity as seen in MM. Thus, explaining the causes of the disparity in MGUS will shed light on the causes of the disparity in MM. We (MPIs Cozen, Desai and Bertrand) are submitting this proposal in response to PAR 19-279,…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at University of California-Irvine